Shares in International Biotechnology Trust (IBT) were boosted by the $2.9 billion takeover of its largest holding Soleno Therapeutics (SLNO). This marks the fourth acquisition within IBT’s portfolio in 2026. Furthermore, the latest deal follows three takeovers of IBT portfolio companies in March alone. IBT managers Ailsa Craig and Marek Poszepczynski expect this M&A wave … Continue reading Boost for IBT as Soleno agrees takeover